Clinical Trial Update: Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing a 3-month triptorelin formulation to a 1-month formulation in Central Precocious Puberty to assess efficacy, metabolism, and bo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty

Drugs mentioned

• Triptorelin (triptorelin)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Central Precocious Puberty | Phase 4 | Status: NOT_YET_RECRUITING